
CLENE INC
Action · US1856341029 · CLNN · A2QE9Y (XNAS)
3,46 USD
28.07.2025 22:58
Cours actuels de CLENE INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
CLNN
|
USD
|
28.07.2025 22:58
|
3,46 USD
| -0,11 USD
-3,08 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | -9,76 % | -5,92 % | 17,29 % | -26,38 % | -21,90 % | -98,41 % |
Profil de l'entreprise pour CLENE INC Action
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Données de l'entreprise
Nom CLENE INC
Société Clene Inc.
Symbole CLNN
Site web
https://clene.com
Marché d'origine
NASDAQ

WKN A2QE9Y
ISIN US1856341029
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Robert Etherington MBA
Capitalisation boursière 37 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 6550 South Millrock Drive, 84121 Salt Lake City
Date d'introduction en bourse 2018-10-18
Fractionnements d'actions
Date | Fractionnement |
---|---|
11.07.2024 | 1:20 |
Changements d'identifiant
Date | De | À |
---|---|---|
31.12.2020 | TOTA | CLNN |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | 84C.F |
NASDAQ | CLNN |
Autres actions
Les investisseurs qui détiennent CLENE INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.